Security Snapshot

SYNAPTICS Inc - Common Stock (SYNA) Institutional Ownership

CUSIP: 87157D109

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

287

Shares (Excl. Options)

38,370,664

Price

$74.02

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
SYNA on Nasdaq
Shares outstanding
38,788,686
Price per share
$72.97
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
38,370,664
Total reported value
$2,840,785,331
% of total 13F portfolios
0%
Share change
+607,977
Value change
+$49,834,536
Number of holders
287
Price from insider filings
$72.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SYNA - SYNAPTICS Inc - Common Stock is tracked under CUSIP 87157D109.
  • 287 institutions reported positions in Q4 2025.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 287 to 95 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,840,785,331 to $246,206,339.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 287 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 87157D109?
CUSIP 87157D109 identifies SYNA - SYNAPTICS Inc - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of SYNAPTICS Inc - Common Stock (SYNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AMERIPRISE FINANCIAL INC 18% +7.6% $610,075,370 +$42,708,607 7,021,238 +7.5% Ameriprise Financial, Inc. 31 Dec 2025
BlackRock, Inc. 12% $209,616,988 4,883,900 BlackRock, Inc. 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 6.9% $187,725,901 2,680,267 Vanguard Portfolio Management 31 Mar 2026
STATE STREET CORP 5.2% $87,121,892 2,029,867 STATE STREET CORPORATION 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $138,554,739 1,978,223 Vanguard Capital Management 31 Mar 2026
ORBIS INVESTMENT MANAGEMENT LTD 4.8% -13% $125,559,655 -$25,584,607 1,833,523 -17% Orbis Investment Management Limited 30 Jun 2025

As of 31 Dec 2025, 287 institutional investors reported holding 38,370,664 shares of SYNAPTICS Inc - Common Stock (SYNA). This represents 99% of the company’s total 38,788,686 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of SYNAPTICS Inc - Common Stock (SYNA) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
AMERIPRISE FINANCIAL INC 18% 7,021,238 +7.5% 0.12% $519,712,412
BlackRock, Inc. 14% 5,343,402 -3.6% 0.01% $395,518,617
VANGUARD GROUP INC 12% 4,607,318 -0.46% 0% $341,033,678
STATE STREET CORP 5.1% 1,985,691 -0.76% 0% $146,980,848
Orbis Allan Gray Ltd 4% 1,536,228 +9.9% 0.48% $113,711,596
FMR LLC 3.9% 1,523,860 -0.66% 0.01% $112,796,134
GEODE CAPITAL MANAGEMENT, LLC 2.6% 1,000,456 +1.7% 0% $74,065,605
DIMENSIONAL FUND ADVISORS LP 2.5% 980,765 -17% 0.02% $72,598,534
Bank of New York Mellon Corp 2.3% 894,004 -2.2% 0.01% $66,174,143
CITADEL ADVISORS LLC 2.1% 818,585 +13% 0.04% $60,591,662
PRICE T ROWE ASSOCIATES INC /MD/ 2.1% 814,684 +470% 0.01% $60,304,000
VICTORY CAPITAL MANAGEMENT INC 2% 769,766 +2.6% 0.03% $56,978,080
Trigran Investments, Inc. 1.8% 692,587 +4.7% 10% $51,265,290
UBS Group AG 1.7% 652,611 +5.8% 0.01% $48,306,267
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 520,119 +4.1% 0.01% $38,499,208
NORTHERN TRUST CORP 1.3% 507,686 -4.1% 0% $37,578,918
GOLDMAN SACHS GROUP INC 1.1% 431,289 +40% 0% $31,924,012
MORGAN STANLEY 0.94% 364,846 +20% 0% $27,005,949
Bragg Financial Advisors, Inc 0.92% 356,075 +0.66% 0.86% $26,356,708
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 0.92% 355,440 0% 0.04% $26,310,000
EMERALD ADVISERS, LLC 0.87% 339,113 0.77% $25,101,144
DEUTSCHE BANK AG\ 0.8% 309,139 +28% 0.01% $22,882,468
Squarepoint Ops LLC 0.74% 288,655 +23% 0.04% $21,366,243
SEGALL BRYANT & HAMILL, LLC 0.71% 275,093 -43% 0.28% $20,362,384
PEREGRINE CAPITAL MANAGEMENT LLC 0.63% 243,815 -2.6% 0.55% $18,047,186

Institutional Holders of SYNAPTICS Inc - Common Stock (SYNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 3,519,050 $246,206,339 +$25,655,253 $70.04 95
2025 Q4 38,370,664 $2,840,785,331 +$49,834,536 $74.02 287
2025 Q3 37,553,235 $2,566,274,935 -$29,842,847 $68.34 288
2025 Q2 37,998,342 $2,463,078,188 -$59,886,678 $64.82 274
2025 Q1 38,929,568 $2,480,170,514 -$29,024,417 $63.72 264
2024 Q4 39,182,700 $2,990,693,512 +$91,739,780 $76.32 262
2024 Q3 37,789,046 $2,931,680,393 -$117,642,635 $77.58 264
2024 Q2 37,992,914 $3,350,735,813 +$102,360,896 $88.20 262
2024 Q1 36,768,660 $3,587,848,393 +$984,468 $97.56 279
2023 Q4 36,753,578 $4,193,071,361 +$42,922,926 $114.08 277
2023 Q3 36,430,688 $3,258,063,026 +$69,600,853 $89.44 272
2023 Q2 35,665,144 $3,045,704,475 -$33,532,991 $85.38 270
2023 Q1 35,682,736 $3,965,804,081 -$75,996,442 $111.15 315
2022 Q4 36,552,733 $3,479,942,422 -$122,063,477 $95.16 308
2022 Q3 37,902,591 $3,752,580,118 -$95,507,700 $99.01 291
2022 Q2 38,715,734 $4,572,764,013 +$1,915,006 $118.05 303
2022 Q1 38,234,067 $7,628,896,749 +$395,591,429 $199.50 355
2021 Q4 35,892,360 $10,390,811,262 +$53,248,977 $289.51 355
2021 Q3 36,091,937 $6,486,678,103 +$17,438,982 $179.73 307
2021 Q2 36,108,020 $5,617,716,086 -$47,897,758 $155.58 300
2021 Q1 36,435,597 $4,934,157,173 +$147,504,981 $135.42 289
2020 Q4 35,525,786 $3,424,867,594 +$45,757,762 $96.40 274
2020 Q3 34,863,698 $2,803,694,770 -$46,798,610 $80.42 249
2020 Q2 35,434,984 $2,129,501,774 +$11,785,658 $60.12 230
2020 Q1 35,522,378 $2,055,765,612 +$68,727,535 $57.87 234
2019 Q4 34,302,479 $2,256,214,260 +$143,763,043 $65.77 227
2019 Q3 32,264,519 $1,288,876,604 -$27,404,155 $39.95 190
2019 Q2 33,440,320 $974,360,675 -$14,373,786 $29.14 186
2019 Q1 33,467,597 $1,331,188,682 -$13,537,977 $39.75 203
2018 Q4 34,067,165 $1,267,947,567 -$12,160,732 $37.21 204
2018 Q3 34,076,513 $1,554,567,892 -$64,023,091 $45.62 227
2018 Q2 35,224,947 $1,774,064,413 -$9,823,373 $50.37 237
2018 Q1 35,437,581 $1,620,555,545 +$53,232,651 $45.73 241
2017 Q4 34,603,777 $1,382,369,518 -$68,420,885 $39.94 234
2017 Q3 36,132,248 $1,415,774,397 +$55,514,650 $39.18 235
2017 Q2 34,258,991 $1,771,664,113 -$49,327,636 $51.71 258
2017 Q1 35,269,691 $1,746,478,237 +$296,462,421 $49.51 257
2016 Q4 32,849,535 $1,760,358,720 -$5,717,862 $53.58 250
2016 Q3 32,694,294 $1,914,011,507 +$68,196,351 $58.58 279
2016 Q2 31,620,356 $1,699,590,816 -$214,064,738 $53.75 265
2016 Q1 34,434,605 $2,745,801,650 +$13,681,662 $79.74 294
2015 Q4 34,286,714 $2,753,565,193 -$24,983,635 $80.34 286
2015 Q3 34,590,805 $2,851,828,455 -$204,900,910 $82.46 283
2015 Q2 37,064,560 $3,214,404,927 +$123,375,407 $86.73 320
2015 Q1 35,706,960 $2,901,411,434 +$274,140,706 $81.30 300
2014 Q4 32,604,268 $2,244,133,457 -$116,932,504 $68.84 291
2014 Q3 33,908,625 $2,482,133,675 -$84,883,546 $73.20 309
2014 Q2 34,718,210 $3,146,284,770 -$289,869,854 $90.64 282
2014 Q1 38,327,606 $2,300,089,146 +$184,988,740 $60.02 279
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .